Baseline demographics and clinical characteristics.
| Randomised | |||
|---|---|---|---|
| Intervention | Standard care | Non-participants | |
| n = 2958 | n = 788 | n = 639 | |
| Age group (years) | |||
| 40–49 (%) | 578 (20) | 156 (20) | 73 (11) |
| 50–59 (%) | 838 (28) | 206 (26) | 130 (20) |
| 60–69 (%) | 825 (28) | 221 (28) | 188 (29) |
| 70–79 (%) | 560 (19) | 162 (21) | 165 (26) |
| ≥80 (%) | 157 (5) | 43 (6) | 83 (13) |
| Female (%) | 1838 (62) | 461 (59) | 316 (50) |
| Ethnic group white (%)a | 2797 (95) | 740 (94) | 593 (93) |
| Long-term illness (%) | 1140 (39) | 298 (38) | 261 (41) |
| Symptoms | |||
| Leakage (%)b | 2392 (82) | 618 (79) | 379 (59) |
| Frequency (%)c | 1563 (53) | 376 (48) | 187 (29) |
| Urgency (%)d | 1927 (65) | 529 (67) | 240 (38) |
| Nocturia (%)e | 1070 (36) | 285 (36) | 189 (30) |
| Impact Median impact score (IQR)f | 5 (2 to 10) | 4 (2 to 9) | 1 (0 to 3) |
| Self-report | |||
| Mild or no problem (%)g | 1560 (53) | 427 (54) | 530 (84) |
| Satisfied with current urinary symptoms for rest of life (%)h | 888 (30) | 270 (34) | 438 (69) |